Myocardial ischemia/reperfusion (I/R) injury is associated with contractile dysfunction, arrhythmias, and myocyte death. Intracellular Ca 
. The rate of active muscle relaxation is determined largely by the Ca 2+ uptake function of SERCA2a (35) . Acute myocardial ischemia/reperfusion (I/R) injury is associated with contractile dysfunction, arrhythmias, myocardial infarction, and sudden death (5) . While the causes of myocardial I/R injury are multifactorial, it is well known that intracellular Ca 2+ overload with reduced expression and/or activity of SERCA2a plays a prominent role (32, 37, 42) . High levels of oxygen-derived free radicals are generated during myocardial I/R and have been shown to damage SERCA2a, potentially contributing to cellular Ca 2+ overload and myocardial injury (16, 22, 49) . Thus, cytosolic free Ca 2+ overload and oxidative stress, either independently or cooperatively, are major contributors to I/R-induced injury.
SERCA2a is the cardiac-specific isoform, and is the major component of beat-to-beat Ca 2+ cycling during excitation-contraction coupling (39) . Recently, it has been reported that SERCA1a, the isoform normally expressed in fast skeletal muscle but not the heart (35) , is more resistant to oxidative stress (43) and acidosis (46) . SERCA1a and SERCA2a possess ~84% sequence homology, and transgenic expression of SERCA1a in the mouse heart has been shown to substitute for SERCA2a both structurally and functionally with concomitant increase in SR Ca 2+ uptake and cardiac contractility (19, 23, 26) . Confocal microscopy demonstrated specific trafficking of SERCA1a to cardiac SR and an increased rate of Ca The striking observation is that with its unique antigenicity and equivalent up regulation, SERCA1a has 2-fold greater velocity of Ca 2+ transport than SERCA2a (6, 40) . Chronic expression of SERCA1a in vivo did not result in significant morphological differences in the hearts with similar mortality curves seen (23).
Several studies have consistently demonstrated that increased expression of SERCA2a improves myocardial contractility and Ca
2+
handling at baseline and in disease conditions including myocardial I/R (3, 7, 9, 15, 31, 33) . Conversely, several investigators have controversially reported that pharmacological inhibition of SERCA may improve postischemic function in stunned heart or in isolated myocardium following I/R (2, 12). The results with SERCA inhibitors, thapsigargin or cyclopiazonic acid, were inconsistent in terms of effectiveness, narrow dose-range and with timing of administration (48) . Interestingly, enhanced SR function in mice overexpressing SERCA1a has recently been shown to partially rescue the heart from hydroxyl radical-induced injury (17). Despite its unique antigenicity and increased Ca 2+ pumping kinetics (6, 40) , it is not known if SERCA1a overexpression can provide myocardial protection against I/R as has been shown with SERCA2a overexpression (7, 9) . Therefore, to further address this issue, the aim of the present study was to test the hypothesis that expression of SERCA1a in the heart will provide cardioprotection characterized by improved postischemic contractile function, reduced intracellular Ca 
Mice
Details regarding the generation and characterization of SERCA1a transgenic (SERCA1a +/+ ) mice have been described previously (26). Briefly, rat SERCA1a cDNA was linked to the mouse cardiac -MHC promoter and SERCA1a +/+ mice were generated. They were bred with FVB/N wild-type mice to establish germ-line transmission. Each mouse was genotyped when it was weaned and only respective littermates served as controls. The experiments were performed in young (16-20 weeks) male mice, and tail-clips were kept to reconfirm the genotypes.
Western Blot Analysis
Tail genotyping (PCR), and SERCA1a and SERCA2a expressions in cardiac homogenates were performed as described previously (26). Hearts from age-matched mice were homogenized in the lysis buffer and protein concentrations were determined by Bio-Rad protein assay. The relative expression of SERCA2a and SERCA1a proteins in SERCA1a transgenic (SERCA1a
hearts, however, 2 of 26 NTG hearts developed pre-ischemic arrhythmias and were excluded from the study.
Following 30 minutes equilibration, hearts underwent 30 min of global ischemia, followed by 45 min reperfusion. At the end of reperfusion, hearts were processed for myocardial infarct size measurement, histopathological examination, Western blot analysis, and electron microscopy. One subset of hearts underwent only 5 min reperfusion to measure free radical generation.
Criteria Used to Determine Arrhythmias
Ventricular tachyarrhythmias, such as ventricular fibrillation (VF) and ventricular tachycardia (VT), with episodes of mechanical alternans are the common occurrence with reperfusion after 30 min of global ischemia. Because these hearts were unpaced, a change in heart rate reflects an important pathophysiological impact of reperfusion on these hearts. Identification of rhythm abnormalities were derived from synchronized recordings of LVP tracings and heart rate, therefore, differentiation of supraventricular and ventricular arrhythmias was not possible in relation to the P wave. According to Merillat et al. (28) and Kawahara et al. (21) , VF was defined as (i) the development of a chaotic, irregular, rapid LVP recordings, (ii) the loss of pulsatile LVP, and (iii) the loss of grossly observable, regular ventricular contraction. VT was defined as a rapid and regular cyclic change in LVP with small amplitude than control.
Mechanical alternans (34) characterized by alternative large and small contractions were defined according to the previously described hallmarks such as (i) the impaired and incomplete relaxation of the strong contraction, (ii) the higher end diastolic pressure of the strong contraction, and (iii) the smaller peak systolic pressure of the weak contraction. When we recorded abnormal contractile rhythms for >30 min of reperfusion, we considered them as persistent rhythm abnormalities.
Light Microscopy
Standard hematoxylin and eosin (HE) staining was used for morphological evaluation. Hearts were fixed in 10% neutral buffered formalin, embedded in paraffin, and serial cross sections (6 µm) made for staining. Digital images of each slide were randomly taken for morphometric evaluation using Spot Basic Software 4.0.4 (Diagnostics International, Inc., USA).
Electron Microscopy
Small tissue blocks (~ 1mm 3 ) were cut from the LV free wall, fixed in 2.5% glutaraldehyde plus 2% paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) overnight at 4°C. The samples were rinsed three times in 0.1M sodium cacodylate buffer and postfixed in 1% osmium tetroxide in the same buffer for 1 h at room temperature, and stained in 1% uranyl acetate for 1h.
The samples were then dehydrated in ascending concentrations of alcohol, treated with propylene oxide, and embedded in Spur resin, and heat polymerized. After polymerization, ultrathin sections (~ 70 nM) were cut using a Leica EM UC6 ultramicrotome, mounted on uncoated copper grids, and stained in 2% uranyl acetate followed by Reynold's lead citrate.
Samples were examined in a Philips CM12 TEM at 80 kV.
EPR Spectroscopy and Spin Trapping
Spin-trapping measurements of oxygen radical generation from TG and NT hearts were performed as described previously (44, 45) . Hearts were infused with 50 mM 5,5-dimethyl-1-pyrroline N-oxide (DMPO), and effluent sampled before ischemia and during the first 3 min of reperfusion. Relative quantitation of radical signals was performed by double integration.
Immunohistochemistry for Nitrotyrosine
These experiments were performed as described previously (44, 45, 47) . Briefly, the formalinfixed paraffin sections (6 µm) from preischemic and postischemic hearts were incubated with rabbit polyclonal anti-nitrotyrosine antibody (1:400 dilution; Upstate, USA), then with the biotinylated secondary, and again with the tertiary, ExtrAvidin alkaline phosphatase (1:800 dilution). Slices from the mouse heart injected with peroxynitrite (1 mmol/L, 0.05 mL; Cayman Chemical Co, USA) into the left ventricle were taken as the positive control, and slices with rabbit IgG instead of anti-nitrotyrosine antibody served as the negative control. Color was developed with fast red.
Ca

2+
Uptake Assay
These experiments were performed as described previously (20). Heart tissue from SERCA1a A fiber optic probe was gently positioned against the LV wall to obtain emission signal from the heart. To suppress motion-induced artifacts and minimize the effects from the curvature of the epicardium, the distance between heart and cable surface was adjusted by monitoring tissue autofluorescence before Rhod-2 loading. Rhod-2 was loaded after spontaneous cardiac contractility became regular (20 min) and no clear signs of damage were evident. Rhod-2 (50 µg) was added to 25 µl of DMSO, thoroughly mixed, and diluted up to 2 ml with perfusion buffer constituting 25 µg/ml. 2 ml of Rhod-2 dye was added without recirculation through a parallel infusion line just above the aortic cannula. During bolusing, the bolus line was opened and the other line was closed. Dye-loading was followed by a 10-min washout period with normal KHB to remove any extracellular dye. LVDP and heart rate were monitored during loading and washout period. Typically, there was a 30-50% decline in LVDP during Rhod-2 loading, followed by complete recovery within 5 min of dye-free perfusion.
Hearts having arrhythmias during washout period were excluded from the study.
Fluorescence was excited with a 150W xenon arc lamp through excitation/emission filters in a modified tissue fluorometer (C&L Instruments, Inc., PA, USA) and the light was directly focused on the photomultiplier tube (PMT). To reduce light interference, the tissue chamber was housed in a solid dark metal box. The area of the light guide facing the heart was 28 mm 2 , providing a complete observation window of the whole heart. The PMT shutters were kept closed except during data acquisition to minimize photobleaching and photooxidation of Rhod-2. The PMT output was collected via PC using an analog-to-digital converter. The ± 6 nM and 753 ± 22 nM in diastole and systole, respectively. These results agree well with those previously reported with Rhod-2 (11) and aequorin (14) in the mouse heart. The diastolic or mean ischemic levels of Rhod-2 fluorescence were used to evaluate Ca 2+ i changes, and were expressed as relative units (RU).
In vivo Myocardial Ischemia-reperfusion
In vivo myocardial ischemia-reperfusion was performed as described previously (47) . Briefly, mouse was anesthetized with a mixture of intraperitoneal ketamine (55 mg/kg) and xylazine (15 mg/kg). After adequate anesthesia and aseptic preparations, the mouse was intubated and ventilated with room air by a MiniVent (Type 845, Harvard Apparatus, USA). The respiratory rate was maintained at 100 breaths/min with a tidal volume of 0.25 ml for a 25-g mouse. After
opening the chest and visualizing the heart, the left anterior descending (LAD) coronary artery was ligated 2 mm below the tip of the left auricle by a 7-0 silk ligature. Occlusion was confirmed by the dramatic change in color (red to pallor) and restricted ventricular motion. After 30-min LAD artery occlusion, the knot was released to start reperfusion, and reperfusion was confirmed by return of the pink-red color and motion of the anterior wall of the LV. The chest was closed in layers with subcutaneous Penicillin G Procaine administered. Buprenorphine (0.1 mg/kg, less than 0.5 ml in volume) was given subcutaneously to reduce postoperative acute pain.
The rectal temperature of the mouse was maintained at 37°C by a thermo heating pad. When mice resumed a normal breathing pattern and started walking, the ventilator was taken off and mice were transferred to a clean cage with free access to food and water.
Myocardial Infarct Size Measurement
In vitro myocardial infarction was measured by 2,3,5-triphenyltetrazolium chloride (TTC, Sigma) staining of heart sections as reported previously (44) . Briefly, the heart was immediately removed after I/R, wrapped in polyethylene wrap and frozen for 10-min for hardening. Then, the heart was serially sectioned into transverse slices (1 mm) by a heart slicer (Zivic laboratories), and incubated in 1% TTC (Sigma) in phosphate buffered saline for 15 min at room temperature to demarcate the viable (brick red) and infarcted (pale) myocardium. Heart slices are then fixed overnight in 10% neutral buffered formaldehyde for better color contrast, and digitally imaged.
Computerized planimetry (with image analysis software Meta Vue, version 6.0) of each section was used to determine percent infarction from the total cross-sectional area of the left ventricle.
In vivo myocardial infarction was measured at 24 hours post reperfusion as previously described with slight modification (47) . Mice were anesthetized, intubated, ventilated, and the chest opened along the previous incision line and the left main coronary artery re-ligated at the same location as before. Evans blue dye (0.2 ml of a 4.0% solution) was injected directly into the inferior vena cava for visualization of the non ischemic zone. The area of the myocardium not stained with Evans blue was defined as the area at risk (AAR). The heart was then rapidly excised, wrapped in polyethylene wrap and frozen for 10-min for hardening, serially sectioned along the short axis (1-mm thick) by a heart slicer, and incubated with 1% TTC for 15 minutes at room temperature for demarcation of the viable and nonviable myocardium within the AAR.
Both sides of each myocardial slice were photographed, and the area of infarction, AAR, and nonrisk area were determined by computerized planimetry as above.
Data Analysis
Results
Characterization of SERCA1a and SERCA2a Expression
Transgenic 
Pre and Post-ischemic Cardiac Function in Perfused Hearts
The functional characteristics of the isolated-perfused hearts are summarized in Table 1 . There were no significant differences in body weight (32±1 vs. 30±1 g, n = 8/group) or heart weight to body weight ratio (0.49±0.01 vs. 0.48±0.01%, n = 8/group) between SERCA1a
and NTG mice ( Table 1) . The intrinsic heart rates were identical, however, baseline coronary flow, LVDP, maximal rates of contraction (+dP/dt) and relaxation (-dP/dt) were significantly higher in SERCA1a
+/+ than in NTG hearts. and NTG hearts subjected to 30-min global ischemia and 45-min reperfusion.
Upon reperfusion, improved recovery of postischemic LV function was seen in SERCA1a
hearts with significantly higher LVDP ( Figure 2A ) and greater recovery in both +dP/dt and -dP/dt than in the NTG hearts (Table 1) . While a similar rise in LVEDP was seen in both groups during ischemia, upon reperfusion LVEDP decreased in SERCA1a
hearts, whereas it increased above ischemic levels in NTG hearts. Throughout the time course of reperfusion, LVEDP remained elevated in NTG compared to SERCA1a
+/+ hearts ( Figure 2B ).
SERCA1a
+/+ hearts started to beat much earlier than NTG hearts and showed diminished incidence of reperfusion arrhythmias ( Table 1 
Myocardial infarction after in vitro I/R
To correlate postischemic LV function with irreversible myocardial injury, myocardial infarct size was determined after I/R (Figures 2D-E) . TTC staining revealed that isolated hearts compared to 39 ± 5% in NTG hearts (P<0.01).
Myocardial Histology before and after in vitro I/R
To determine if alterations in myocardial structure paralleled the differences in functional recovery, light microscopic histological examination was performed. No differences in histological structure were found in HE-stained sections of nonischemic SERCA1a
and NTG hearts, and both appeared structurally normal ( Figures 3A-B) . After I/R, frequent interstitial edema, nuclear vaculation, and contraction band-type changes (arrow) were evident in NTG hearts as early as the first minute of reperfusion ( Figure 3C ) and persisted for 45 min ( Figure   3E ), but only modest changes were seen in SERCA1a +/+ hearts ( Figures 3D and 3F ).
Myocardial ultrastructure before and after in vitro I/R
To further correlate myocardial infarction and histology findings with myocardial ultrastructure, electron microscopic examination was performed. Concordant with light microscopy, no qualitative differences in myocardial ultrastructure were seen between nonischemic SERCA1a
and NTG hearts ( Figures 4A-B) . Orderly distributed myofibrils with normal sarcomere and dark mitochondria containing tightly arranged cristae were seen in both strains. However, after I/R, NTG hearts showed markedly severe ultrastructural damage ( Figure 4C ) with thinning, discontinuation or lysis of myofibrils associated with intracellular edema and misregistration of Z-bands, while in SERCA1a
hearts little change was seen ( Figure 4D ). Most of the mitochondria in NTG hearts were swollen and larger in size with abnormal cristae and loss of matrix, while in SERCA1a
hearts no abnormalities were seen.
EPR Measurements of Free Radical Generation
To determine the magnitude of free radical generation in postischemic hearts, EPR and spintrapping studies were performed using the spin trap DMPO. Before ischemia no radical generation was seen in either strain (upper tracings in Figures 5A-B) . However, over the first minute of reperfusion, both SERCA1a hearts (lower tracings in Figures 5A-B) .
Immunohistochemistry for Nitrotyrosine
Immunohistochemical staining of nitrotyrosine, a marker of peroxynitrite formation (32,33) was performed in nonischemic and postischemic hearts. In positive controls with peroxynitrite infusion, strong dense red nitrotyrosine staining of the vascular bed and weaker staining within the myocytes were seen throughout the heart ( Figure 6A ). There was no staining in the negative control ( Figures 6B) . In nonischemic myocardium, there was no positive staining for nitrotyrosine ( Figures 6C-D) . In postischemic myocardium, focal positive nitrotyrosine staining was detectable upon reperfusion within the myocytes of both SERCA1a
and NTG hearts at 1 min of reperfusion ( Figures 6E-F) . The intensity of nitrotyrosine staining in reperfused myocardium was similar in both strains.
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Myocardial infarction ( Figure 8A 
Discussion
The major goal of this study was to determine if cardiac expression of SERCA1a can protect the heart against I/R injury and the mechanism of this protection. We observe that SERCA1a 
Beneficial Role of SERCA Upregulation in Cardiac Protection
While increased SERCA2a expression improves Ca 2+ cycling and cardiac function in different experimental conditions (3, 15, 31, 33) , the use of SERCA1a to improve cardiac contractility has been only recently attempted (8). This is the first study to investigate the efficacy of cardiac SERCA1a overexpression in protecting the heart against I/R injury both in vitro and in vivo. We chose to study the effect of SERCA1a since it has been shown to have higher calcium transport velocity than SERCA2a, and is associated with faster rates of contraction and relaxation in adult cardiomyocytes compared to equivalent SERCA2a overexpression (3, 6, 26, 40 hearts compared with NTG hearts (Table 1) .
Interestingly, baseline coronary flow was significantly higher in SERCA1a (Table 1 and Figure 2B ).
This improved postischemic contractile recovery in SERCA1a
+/+ hearts was associated with 2.5-fold increase in the recovery of LVDP (Figure 2A ) and about 2-fold decrease in myocardial infarct size compared to NTG hearts ( Figure 2E ). Concordantly, LVEDP after 45 min of reperfusion was about 2-fold lower in SERCA1a
hearts ( Figure 2B ), and both plus and minus maximal dP/dt were 8 and 6-fold higher respectively in SERCA1a
+/+ hearts ( Table 1) . The decreased infarct size and improved contractile recovery in SERCA1a +/+ hearts are due to greater preservation of myocardial integrity with less myocardial structural damage seen by light and electron microscopy ( Figures 3 and 4) . These striking differences between SERCA1a
+/+ and NTG hearts during reperfusion clearly show that SERCA1a expression imparts prominent myocardial protection inspite of the 50% reduction in constitutive SERCA2a.
Consistent with the isolated heart data, our studies in an in vivo regional model of I/R also showed markedly smaller infarct size in SERCA1a 
SERCA Upregulation and Postischemic Reactive Oxygen and Nitrogen Species
The burst of reactive oxygen species (ROS) during reperfusion is another key central mechanism of reperfusion injury. Potent oxidants and free radicals such as superoxide anion, hydroxyl radical, and peroxynitrite are formed during postischemic reperfusion and reach highest concentrations during the first minutes of reperfusion (4, 49) . Oxygen-derived free radicals have been reported to damage the SERCA, potentially contributing to Ca It has been shown that the burst of superoxide during the early period of reperfusion reacts with nitric oxide (NO) to form the reactive nitrogen species peroxynitrite in the myocardium, subsequently aggravating reperfusion injury (4, 24, 49, 50) . Interestingly, it has been reported that exogenous peroxynitrite-induced nitration of SERCA2a is associated with a parallel loss of SERCA2a activity in skeletal muscle, whereas SERCA1a did not become nitrated (43) .
Recently, it has been reported that increased nitration of SERCA2a protein causes impaired cardiac relaxation in heart failure patients (25). While we observed similar degree of nitrotyrosine staining in the postischemic hearts of both strains ( Figure 6E ,F), SERCA1a
hearts displayed improved postischemic contractile recovery with significantly lower LVEDP.
Thus, the enhanced ability to pump back Ca 2+ into the SR and the resultant lower cytosolic Ca 2+ levels do not affect the magnitude of free radical generation or peroxynitrite-mediated nitration.
Implications of SERCA Modulation in Cardioprotection
Since defective SR Ca 2+ handling plays a major role in myocardial I/R-induced contractile dysfunction and arrhythmias (32, 37, 42, 48) , the SR has recently been proposed as a critical primary target for reperfusion protection (36 
